Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients-Reference-Cited by-同舟云学术

Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients

Published:2014-07-07 Issue:10 Volume:54 Page:1194-1204
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol. Carcinog.

Author:

Jiang Xianhan¹²,Zhong Weide³,Huang Hai⁴,He Huichan³,Jiang Funeng³,Chen Yanru³,Yue Fei²,Zou Jing²,Li Xun¹,He Yongzhong¹,You Pan²,Yang Weiqiang¹,Lai Yiming⁴,Wang Fen²,Liu Leyuan²

Affiliation:

1. Department of Urology; The Fifth Affiliated Hospital of Guangzhou Medical University; Guangzhou 510700 China

2. Center for Cancer and Stem Cell Biology; Institute of Biosciences and Technology; Texas A&M Health Science Center; Houston Texas 77030

3. Department of Urology; Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics; Guangzhou First People's Hospital; Guangzhou Medical University; Guangzhou 510180 China

4. Department of Urology; The Sun Yat-Sen Memorial Hospital; Sun Yat-Sen University; Guangzhou China

Funder

DOD New Investigator Award

NIH

China National Natural Science Foundation for Young Scientists

The Guangdong Province Natural Science Foundation

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mc.22193/fullpdf